Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1

Interventions

Cyclophosphamide 17 Etoposide 10 fludarabine 9 Whole-Body Irradiation 9 Brentuximab Vedotin 9 Melphalan 8 fludarabine phosphate 7 Vincristine 7 Mycophenolic Acid 7 Gemcitabine 7 Doxorubicin 7 Prednisone 6 Granulocyte Colony-Stimulating Factor 6 Busulfan 6 Vorinostat 5 Rituximab 5 Peripheral Blood Stem Cell Transplantation 5 Lenalidomide 5 Filgrastim 5 Cytarabine 5 Bortezomib 5 romidepsin 4 pembrolizumab 4 duvelisib 4 Tacrolimus 4 Stem Cell Transplantation 4 Carmustine 4 etoposide phosphate 3 Sirolimus 3 Dexamethasone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, T-Cell × Flavin-Adenine Dinucleotide × Clear all

NCT00840385 2010-09-15

FAD

Fudan University

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡